CSE: $EAT / OTCQB: $SPLIF hot cannabis, great exposure to

New Post Public Reply Private Reply Replies (0) Message Board
budfoxfun
116
CSE: $EAT / OTCQB: $SPLIF hot cannabis, great exposure to the cannabis sector! Nutritional High continues to capitalize on the successes of its wholly-owned subsidiary company, Calyx Brands. Through Calyx, Nutritional High operates a robust distribution business that covers the entire State of California. Nutritional High has reported major successes such as our Q3 2019 figure of $6.3 million in revenue from the sale of cannabis related products by Calyx. Gross margin for the same period was 26.5%. The Q3 2019 filings also marked five quarters of continuous revenue growth for the company starting Q3 2018, which produced revenue of $1.7 million and gross margin of 19.6%. The latest quarter represents an increase of 368% year over year in cannabis sales. Calyx and Nutritional High recognize the need to work collaboratively rather than competitively with our distribution brands, and we have been working closely with our partners in this regard. The company plans to reveal expansion plans for its distribution division in the coming months.

In terms of expansion on the horizon, Nutritional High is looking toward potential international expansion. Currently, the Nutritional High team is working to refine its current business plan for Canada. In particular, the company is looking forward to the second major round of legalization regulations from Health Canada that will include edibles and other infused cannabis products. In addition to Canada, the Nutritional High team is currently developing a strategy to tackle Asian markets, starting with Thailand which saw the legalization of medical marijuana last year. The company sees an opportunity to work with its current partners in Asia to establish an early foothold on what the company believes could be a very lucrative market.

The Bottom Line - We believe that Nutritional High could be on track to build the next Canopy Growth (NYSE-CGC) here in the United States. The company also has laid the potential groundwork for international expansion. Nutritional High's current market cap is 33 million dollars compared to Canopy Growth's 7.6 Billion dollar market cap. The company's vertically integrated company structure is also identical to Canopy Growth's business model but we feel the aggressive targeting of the U.S market offers a greater opportunity for growth as more states legalize in the coming years. In terms of branding and products, Nutritional High currently operates one of Colorado's largest state of the art oil extraction and infused edibles facilities. In addition to products, the company's wholly owned subsidiary Calyx Brands is creating major waves in the distribution realm and adds potential exponential growth to the company. The company's valuation should be much higher as its revenues are exploding quarter over quarter. Management has outlined a clear path to profitability and their Calyx Brands subsidiary will add enormously to its bottom line as sales partnerships are growing fast and furious. The company is trading at only 4X sales which is well below its industry peers. This is a real deal with quality management, a highly demanded product line and the company's infrastructure is building out nicely. We are looking for a valuation of 10x sales(This year's sales topped 9 million dollars) which would increase the company's valuation exponentially, offering investors a substantial gain from current levels.

https://www.privateequitymarkets.us/newslette...-in-the-us

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 1

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 1

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 1

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
Insurance 101: Know Your Limits and Deductibles

Updated Category News Views 4

It might not exactly be cocktail party fodder, but boy, skipping on understanding your homeowners insurance is a shortcut straight to financial hell. You’re living in St. Albans, WV, in a home that’s probably your biggest investment. Let’s talk about this before you find yourself in a mess you should've seen coming. Why Coverage Limits Matter a Whole Lot Listen up,...

Continue Reading
vivo and UNESCO Unite Youth for Nature Stories

Updated Category News Views 4

Young Creators Explore Nature Through a New Lens Pontremoli, Italy just became the backdrop for an extraordinary gathering of young visionaries. From August 31 to September 5, UNESCO’s Man and the Biosphere (MAB) Programme and vivo wrapped their 2026 Capture the Future initiative in the lush landscapes of the Appennino Tosco Emiliano Biosphere Reserve. It’s one thing...

Continue Reading
Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 4

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Nurminen Logistics Doubles Sweden–Italy Rail Capacity

Updated Category News Views 4

Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...

Continue Reading
ACG Moves to Acquire Ke?kek for $7.85M Gold Venture

Updated Category News Views 3

Here's the scoop: ACG Metals Limited is stepping up the game, attempting to snag the Ke?kek gold project in a deal worth up to $7.85 million. This move, they say, is all about bolstering the future of their gold production—and squeezing every ounce out of that Gediktepe facility in Türkiye. It's like squeezing juice from a lemon that's still got a bit of life left....

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 3

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Consumer365 Highlights Happy Head's Personalized Hair Solutions

Updated Category News Views 1

Tailored Hair Loss Solutions by Happy Head Imagine trying to fit a square peg in a round hole. That's what one-size-fits-all approaches often feel like in the world of hair loss treatments. Happy Head, recognized by Consumer365, takes that notion and turns it on its head, offering personalized minoxidil formulations for women. The key word here is personalized. More Than...

Continue Reading

Top 5 Most Recently Viewed Articles

Avocados From Mexico Celebrates Certification as Great Employer

Updated Category News Views 51

Avocados From Mexico Achieves Prestigious Great Place To Work Certification Avocados From Mexico is widely recognized not just as the top-selling avocado brand in the United States, but also as a Certified Great Place To Work. This esteemed certification reflects the positive feedback from current employees regarding their experiences within the company. An impressive 97%...

Continue Reading
Etex Shows Stability and Growth Amid Market Challenges in 2025

Updated Category News Views 370

Etex's Strong Half-Year Financial Performance Etex has demonstrated significant resilience in its half-year financial performance, navigating a construction environment that remains largely unpredictable. This strength is highlighted by a steady sales volume and healthy margins, confirming the company's expectations for the period. Overview of Financial Results The...

Continue Reading
First Horizon Bank Becomes Official Partner of NC Courage

Updated Category News Views 111

First Horizon Bank Officially Partners with NC Courage In an exciting development for women's sports, First Horizon Bank (NYSE: FHN) has been named the Official Bank of the North Carolina Courage, marking the start of a multiyear partnership aimed at bolstering community initiatives. This collaboration is an incredible opportunity to enhance support for women's athletics...

Continue Reading
Curis Announces Upcoming Presentations on Emavusertib Research

Updated Category News Views 193

Curis Prepares for Major Presentations at SNO Meeting LEXINGTON, Mass. — Curis, Inc. (NASDAQ: CRIS) is excited to share that the company will participate in the prestigious 30th Annual Meeting of the Society for Neuro-Oncology (SNO). This event is taking place soon, and Curis intends to showcase significant clinical data regarding emavusertib (CA-4948), a promising...

Continue Reading
Novel Approach to PTSD Treatment Unveiled in Recent Study

Updated Category News Views 391

Recent Advancements in PTSD Research Otsuka Pharmaceutical Development & Commercialization, Inc. and Lundbeck LLC have made headlines with the publication of a Phase 3 trial of brexpiprazole combined with sertraline for treating Post-Traumatic Stress Disorder (PTSD) in adults. The findings, appearing in JAMA Psychiatry, indicate a significant improvement in PTSD symptoms...

Continue Reading